Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905

被引:4
|
作者
Li, S [1 ]
Zhang, H [1 ]
Hoff, H [1 ]
Sell, C [1 ]
机构
[1] Allegheny Univ, MCP Hahnemann Sch Med, Dept Pathol & Lab Med, Gerontol Res Ctr, Philadelphia, PA 19129 USA
关键词
insulin-like growth factor 1; tyrosine kinase; cell proliferation; transformation;
D O I
10.1006/excr.1998.4167
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have created a deletion mutant of the insulinlike growth factor type 1 receptor (IGF-1 R) which lacks the 36 amino acids (aa) immediately N-terminal to the transmembrane domain (Delta 870-905 IGF-1 R), This region has been reported to have a negative effect on the transforming potential of an avian sarcoma virus gag-IGF-l R fusion protein, We have sought to determine whether this region plays a similar role in the intact IGF-1 R. Analysis of the tyrosine kinase activity of the Delta 870-905 IGF-1 R shows that the mutant receptor is autophosphorylated without IGF-1 stimulation, indicating that the tyrosine kinase domain is constitutively active, In addition, processing of the receptor is decreased, resulting in accumulation of a high molecular weight proreceptor containing both a and beta-subunits. A well-characterized substrate of the IGF-1 R, IRS-1, is constitutively phosphorylated by the Delta 870-905 IGF-1 R and phosphoinositide (PI) 3-kinase activity, which is normally activated by the phosphorylation of IRS-1 following IGF-1 stimulation, is increased even in the absence of IGF-1. A second intracellular signal pathway normally activated by IGF-I, the MAP kinase pathway, showed no increase in activity in the absence of IGF-1. The Delta 870-905 IGF-1 R promoted cell proliferation only in the presence of IGF-1. We conclude that this deletion increases the basal activity of the IGF-1 receptor tyrosine kinase and activates PI 3-kinase, but is unable to stimulate MAP kinase in the absence of ligand, These results confirm those seen in the gag-IGF-l R fusion protein and indicate that aa 870-905 exert a negative effect on the tyrosine kinase domain of the beta-subunit of the IGF-1 R. (C) 1998 Academic Press.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [1] The contradictions of the insulin-like growth factor 1 receptor
    Baserga, R
    ONCOGENE, 2000, 19 (49) : 5574 - 5581
  • [2] The contradictions of the insulin-like growth factor 1 receptor
    Renato Baserga
    Oncogene, 2000, 19 : 5574 - 5581
  • [3] The type 1 insulin-like growth factor receptor and resistance to DACH1
    DeAngelis, Tiziana
    Wu, Kongming
    Pestell, Richard
    Baserga, Renato
    CELL CYCLE, 2011, 10 (12) : 1956 - 1959
  • [4] Seasonal expressions of growth hormone receptor, insulin-like growth factor 1 and insulin-like growth factor 1 receptor in the scented glands of the muskrats (Ondatra zibethicus)
    Xie, Wenqian
    Tang, Zeqi
    Guo, Yuanyuan
    Zhang, Chunjiao
    Zhang, Haolin
    Han, Yingying
    Yuan, Zhengrong
    Weng, Qiang
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2019, 281 : 58 - 66
  • [5] Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: Implications for cellular potency and selectivity over insulin receptor
    Wood, Edgar R.
    Shewchuk, Lisa
    Hassel, Anne
    Nichols, Jim
    Truesdale, Anne T.
    Smith, Danielle
    Carter, H. Luke
    Weaver, Kurt
    Barrett, George
    Leesnitzer, Tony
    Alvarez, Emilio
    Bardera, Ana Isabel
    Alamillo, Amelia
    Cantizani, Juan
    Martin, Julio
    Smith, Gary K.
    Jensen, David E.
    Xie, Hongbo
    Mook, Robert
    Kumar, Rakesh
    Kuntz, Kevin
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (12) : 1438 - 1447
  • [6] Glycan Modulation of Insulin-like Growth Factor-1 Receptor
    Boothello, Rio S.
    Sankaranarayanan, Nehru Viji
    Sistla, Jyothi C.
    Nagarajan, Balaji
    Sharon, Chetna
    Chittum, John E.
    Niyaz, Rabiya Y.
    Roy, Swarnali
    Nandi, Aditi
    O'Hara, Connor P.
    Gangji, Rahaman Navaz
    Afosah, Daniel K.
    Ongolu, Ravikumar
    Patel, Bhaumik B.
    Desai, Umesh R.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (49)
  • [7] Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis
    Aleem, Eiman
    Nehrbass, Dirk
    Klimek, Fritz
    Mayer, Doris
    Bannasch, Peter
    TOXICOLOGIC PATHOLOGY, 2011, 39 (03) : 524 - 543
  • [8] Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition
    Hurcombe, Jennifer A.
    Barrington, Fern
    Marchetti, Micol
    Betin, Virginie M. S.
    Bowen, Emily E.
    Lay, Abigail C.
    Ni, Lan
    Dayalan, Lusyan
    Pope, Robert J. P.
    Brinkkoetter, Paul T.
    Holzenberger, Martin
    Welsh, Gavin I.
    Coward, Richard J. M.
    ISCIENCE, 2024, 27 (05)
  • [9] Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling
    Yang, Shasha
    Deng, Huacong
    Zhang, Qunzhou
    Xie, Jing
    Zeng, Hui
    Jin, Xiaolong
    Ling, Zixi
    Shan, Qiaoyun
    Liu, Momo
    Ma, Yuefei
    Tang, Juan
    Wei, Qianping
    PLOS ONE, 2016, 11 (03):
  • [10] Local Expression of Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, and Estrogen Receptor Alpha in Ovarian Cancer
    An, Yuan
    Cai, Liying
    Wang, Yuguang
    Zhu, Daling
    Guan, Yongmei
    Zheng, Jianhua
    ONKOLOGIE, 2009, 32 (11): : 638 - 644